Literature DB >> 25596529

Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis.

Chithra Keembiyehetty1, Dona C Love1, Katryn R Harwood1, Oksana Gavrilova2, Marcella E Comly1, John A Hanover3.   

Abstract

O-GlcNAc cycling is maintained by the reciprocal activities of the O-GlcNAc transferase and the O-GlcNAcase (OGA) enzymes. O-GlcNAc transferase is responsible for O-GlcNAc addition to serine and threonine (Ser/Thr) residues and OGA for its removal. Although the Oga gene (MGEA5) is a documented human diabetes susceptibility locus, its role in maintaining insulin-glucose homeostasis is unclear. Here, we report a conditional disruption of the Oga gene in the mouse. The resulting homozygous Oga null (KO) animals lack OGA enzymatic activity and exhibit elevated levels of the O-GlcNAc modification. The Oga KO animals showed nearly complete perinatal lethality associated with low circulating glucose and low liver glycogen stores. Defective insulin-responsive GSK3β phosphorylation was observed in both heterozygous (HET) and KO Oga animals. Although Oga HET animals were viable, they exhibited alterations in both transcription and metabolism. Transcriptome analysis using mouse embryonic fibroblasts revealed deregulation in the transcripts of both HET and KO animals specifically in genes associated with metabolism and growth. Additionally, metabolic profiling showed increased fat accumulation in HET and KO animals compared with WT, which was increased by a high fat diet. Reduced insulin sensitivity, glucose tolerance, and hyperleptinemia were also observed in HET and KO female mice. Notably, the respiratory exchange ratio of the HET animals was higher than that observed in WT animals, indicating the preferential utilization of glucose as an energy source. These results suggest that the loss of mouse OGA leads to defects in metabolic homeostasis culminating in obesity and insulin resistance.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Glycogen Synthase Kinase 3 (GSK-3); Metabolism; Mouse Genetics; O-GlcNAcase; O-GlcNAcylation; O-Linked N-Acetylglucosamine (O-GlcNAc); Perinatal Lethality

Mesh:

Substances:

Year:  2015        PMID: 25596529      PMCID: PMC4358131          DOI: 10.1074/jbc.M114.617779

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  84 in total

Review 1.  Cre recombinase: the universal reagent for genome tailoring.

Authors:  A Nagy
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

Review 2.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

3.  Gsα deficiency in the paraventricular nucleus of the hypothalamus partially contributes to obesity associated with Gsα mutations.

Authors:  Min Chen; Alta Berger; Ahmed Kablan; Jiandi Zhang; Oksana Gavrilova; Lee S Weinstein
Journal:  Endocrinology       Date:  2012-06-25       Impact factor: 4.736

4.  Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes.

Authors:  S J Oreña; A J Torchia; R S Garofalo
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

5.  A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans.

Authors:  Donna M Lehman; Dong-Jing Fu; Angela B Freeman; Kelly J Hunt; Robin J Leach; Teresa Johnson-Pais; Jeanette Hamlington; Thomas D Dyer; Rector Arya; Hanna Abboud; Harald H H Göring; Ravindranath Duggirala; John Blangero; Robert J Konrad; Michael P Stern
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

6.  Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.

Authors:  Michele E Forsythe; Dona C Love; Brooke D Lazarus; Eun Ju Kim; William A Prinz; Gilbert Ashwell; Michael W Krause; John A Hanover
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

7.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.

Authors:  Keith Vosseller; Lance Wells; M Daniel Lane; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

8.  Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.

Authors:  Yoshihiro Akimoto; Gerald W Hart; Lance Wells; Keith Vosseller; Koji Yamamoto; Eiji Munetomo; Mica Ohara-Imaizumi; Chiyono Nishiwaki; Shinya Nagamatsu; Hiroshi Hirano; Hayato Kawakami
Journal:  Glycobiology       Date:  2006-11-09       Impact factor: 4.313

9.  Regulation of Akt signaling by O-GlcNAc in euglycemia.

Authors:  Yudi A Soesanto; Bai Luo; Deborah Jones; Rodrick Taylor; J Scott Gabrielsen; Glendon Parker; Donald A McClain
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-26       Impact factor: 4.310

Review 10.  Chromosome imbalance as a driver of sex disparity in disease.

Authors:  Lara K Abramowitz; Stéphanie Olivier-Van Stichelen; John A Hanover
Journal:  J Genomics       Date:  2014-04-01
View more
  64 in total

Review 1.  The sweet side of the cell cycle.

Authors:  Ee Phie Tan; Francesca E Duncan; Chad Slawson
Journal:  Biochem Soc Trans       Date:  2017-04-15       Impact factor: 5.407

2.  A genetic model to study O-GlcNAc cycling in immortalized mouse embryonic fibroblasts.

Authors:  Melissa M St Amand; Michelle R Bond; Julia Riedy; Marcella Comly; Joseph Shiloach; John A Hanover
Journal:  J Biol Chem       Date:  2018-06-28       Impact factor: 5.157

Review 3.  You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics.

Authors:  Stéphanie Olivier-Van Stichelen; John A Hanover
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2015-07       Impact factor: 4.294

Review 4.  Nutrient regulation of gene expression by O-GlcNAcylation of chromatin.

Authors:  Stéphan Hardivillé; Gerald W Hart
Journal:  Curr Opin Chem Biol       Date:  2016-06-17       Impact factor: 8.822

5.  Dynamic Glycosylation Governs the Vertebrate COPII Protein Trafficking Pathway.

Authors:  Nathan J Cox; Gokhan Unlu; Brittany J Bisnett; Thomas R Meister; Brett M Condon; Peter M Luo; Timothy J Smith; Michael Hanna; Abhishek Chhetri; Erik J Soderblom; Anjon Audhya; Ela W Knapik; Michael Boyce
Journal:  Biochemistry       Date:  2017-12-15       Impact factor: 3.162

Review 6.  Critical observations that shaped our understanding of the function(s) of intracellular glycosylation (O-GlcNAc).

Authors:  Natasha E Zachara
Journal:  FEBS Lett       Date:  2018-11-24       Impact factor: 4.124

7.  Iron down-regulates leptin by suppressing protein O-GlcNAc modification in adipocytes, resulting in decreased levels of O-glycosylated CREB.

Authors:  Yan Gao; Jingfang Liu; Zhenzhong Bai; Sandy Sink; Chengyu Zhao; Felipe Ramos Lorenzo; Donald A McClain
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

8.  Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.

Authors:  Ilhan Akan; Dona C Love; Katryn R Harwood; Michelle R Bond; John A Hanover
Journal:  J Biol Chem       Date:  2016-03-08       Impact factor: 5.157

Review 9.  Molecular Functions of Glycoconjugates in Autophagy.

Authors:  Kamau Fahie; Natasha E Zachara
Journal:  J Mol Biol       Date:  2016-06-23       Impact factor: 5.469

10.  O-GlcNAcase Is an RNA Polymerase II Elongation Factor Coupled to Pausing Factors SPT5 and TIF1β.

Authors:  Melissa Resto; Bong-Hyun Kim; Alfonso G Fernandez; Brian J Abraham; Keji Zhao; Brian A Lewis
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.